Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
During chronic kidney disease (CKD), there is a progressive accumulation of toxic solutes due to inadequate renal clearance. Here, the interaction between uremic toxins and two important efflux pumps, viz. multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP) was investig...
Main Authors: | Henricus A M Mutsaers, Lambertus P van den Heuvel, Lauke H J Ringens, Anita C A Dankers, Frans G M Russel, Jack F M Wetzels, Joost G Hoenderop, Rosalinde Masereeuw |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3070735?pdf=render |
Similar Items
-
Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
by: Henricus A M Mutsaers, et al.
Published: (2013-01-01) -
Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently
by: Carolien M. S. Schophuizen, et al.
Published: (2015-06-01) -
Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
by: Olivier Deltombe, et al.
Published: (2019-07-01) -
Uremic Solutes in Chronic Kidney Disease and Their Role in Progression.
by: Jan A J G van den Brand, et al.
Published: (2016-01-01) -
Deficiency of Either P-Glycoprotein or Breast Cancer Resistance Protein Protect against Acute Kidney Injury
by: Miriam Huls, et al.
Published: (2010-09-01)